denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
Program: Scientific Workshops
Session: Closing Remarks
Program: Scientific Workshops
Session: Closing Remarks
Friday, December 6, 2024, 4:55 PM-5:00 PM
Disclosures: Seremetis: Novo Nordisk: Current Employment, Current equity holder in publicly-traded company; TEVA: Current equity holder in publicly-traded company.
See more of: Closing Remarks
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
See more of: Scientific Workshop on Decentralized Clinical Trials in Hematology: Reshaping the Traditional Clinical Trial Paradigm With AI Strategies for 'Real World' Patient Representation
See more of: Scientific Workshops
<< Previous Presentation
|
Next Presentation